Galderma is certainly the heavyweight for rosacea treatments and skincare. Rosacea sufferers will be familiar with Metrogel 1% and Oracea as well as their Cetaphil skincare range. More recently Galderma has gained approval for Mirvaso and also has CD5024/Ivermectin in development.
Recent Rosacea Blog Posts
Galderma is set to trial the usage of Soolantra and Oracea in combination to treat sufferers of severe rosacea. What is Severe Rosacea? Severe rosacea is taken here to be participants with at least 20 but not more than 70 papules and pustules. The trial will aim to show that the addition of Oracea to […]
Sales figures for rosacea prescription products are generally hard to come by. This is about as public as they get – the owners of Galderma, Nestle are touting how well Soolantra sales growth is contributing to their profits. Nestlé (NSRGY) Q2 2016 Results – Earnings Call Transcript In Nestlé skin health, we have a consumer […]
Following in the footsteps of making Metrogel 1% available in a pump, Galderma has announced that Mirvaso Gel is now available in a pump dispenser. Previously Galderma has claimed the benefits of a pump over a tube include – better looking dispenser, minimizing waste, easier compliance with prescribing instructions and “facilitating product handling”. Galderma Press […]
A study has been released that headlines a result that even though Soolantra costs more than Finacea, overall it is actually cheaper than Finacea. The study uses a complicated formula to deduce that even though Soolantra sells for more per tube than Finacea, the overall cost versus the benefit you receive shows that Soolantra is […]
We first learnt that Soolantra was available in Australia in November 2015. Australians have been telling us that Soolantra is a private prescription and will cost around $56 for 30gm tube. It appears that Galderma was able to convince Channel 9 News in Australia to cover the availability of Soolantra downunder. Today Channel 9 aired a 2 minute story highlighting […]